CSIMarket
 


Miragen Therapeutics Inc   (MGEN)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Miragen Therapeutics Inc 's Total Debt to Equity

MGEN's quarterly Total Debt to Equity and Total Debt, Equity growth


Despite a net increase in borrowings by 0.42%, Miragen Therapeutics Inc managed to enhance Total Debt to Equity in the third quarter 2020 to 0.42, surpassing the average for Miragen Therapeutics Inc 's Total Debt to Equity.

Within Medical Laboratories industry in the third quarter 2020, 11 other companies have achieved lower Total Debt to Equity than Miragen Therapeutics Inc in the III Quarter 2020. While Total Debt to Equity total ranking has deteriorated compared to the second quarter 2020 from 1290 to 1507 .

Explain Debt to Equity Ratio?
What is the structure of MGEN´s Total Debt?
How valuable is the MGEN´s Equity?


MGEN Total Debt to Equity (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity Change -37.07 % -48.31 % - - -
Y / Y Total Debt Change -12.97 % -15.35 % - - -
Total Debt to Equity MRQ 0.42 0.42 0.53 0.4 0.3
MGEN's Total Ranking # 1507 # 1290 # 1503 # 1460 #
Seq. Equity Change -0.61 % 34.38 % -32 % -30.71 % -18.36 %
Seq. Total Debt Change 0.42 % 5.94 % -10.04 % -9.06 % -2.32 %



Total Debt to Equity third quarter 2020 Company Ranking
Within: No.
Medical Laboratories Industry # 12
Healthcare Sector # 268
Overall Market # 1507


Total Debt to Equity Statistics
High Average Low
0.53 0.39 0.25
(Dec 31 2019)   (Mar 31 2019)




Financial Statements
Miragen Therapeutics Inc 's Equity $ 21 Millions Visit MGEN's Balance sheet
Miragen Therapeutics Inc 's Total Debt $ 9 Millions Visit MGEN's Balance sheet
Source of MGEN's Sales Visit MGEN's Sales by Geography


Cumulative Miragen Therapeutics Inc 's Total Debt to Equity

MGEN's Total Debt to Equity for the trailling 12 Months

MGEN Total Debt to Equity

(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity TTM Growth -37.07 % -48.31 % - - -
Y / Y Total Debt TTM Growth -12.97 % -15.35 % - - -
Total Debt to Equity TTM 0.43 0.39 0.34 0.31 0.28
Total Ranking TTM # 1522 # # 1426 # 999 # 728
Seq. Equity TTM Growth -0.61 % 34.38 % -32 % -30.71 % -18.36 %
Seq. Total Debt TTM Growth 0.42 % 5.94 % -10.04 % -9.06 % -2.32 %


On the trailing twelve months basis Due to the net new borrowings of 0.42% during the trailing twelve months finishing in the III Quarter 2020, cumulativeTotal Debt to Equity improved to 0.43, a new company high.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry only one has achieved lower Total Debt to Equity. While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the III Quarter 2020, compared to the prior period, from 1740 to 1532.

Explain Debt to Equity Ratio?
What is the structure of MGEN´s Total Debt?
How valuable is the MGEN´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Medical Laboratories Industry # 2
Healthcare Sector # 29
Within the Market # 1507


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.43 0.25 0.05
(Sep 30 2020)   (Mar 31 2019)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2020, within Medical Laboratories Industry Total Debt to EquitySep 30 2020 MRQ Total DebtSep 30 2020 MRQ Equity
Opgen inc   1.13 $ 19.316  Millions$ 17.079  Millions
Hologic Inc  1.13 $ 3,058.100  Millions$ 2,707.300  Millions
Charles River Laboratories International inc   1.06 $ 2,016.107  Millions$ 1,901.465  Millions
Pra Health Sciences Inc   0.97 $ 1,280.969  Millions$ 1,325.266  Millions
Syneos Health Inc   0.82 $ 2,538.922  Millions$ 3,096.478  Millions
Quest Diagnostics Inc  0.71 $ 4,573.000  Millions$ 6,446.000  Millions
Laboratory Corporation Of America Holdings  0.70 $ 5,793.900  Millions$ 8,239.100  Millions
Exact Sciences Corporation  0.68 $ 1,578.929  Millions$ 2,337.100  Millions
Invitae Corporation  0.67 $ 279.870  Millions$ 416.551  Millions
Exagen Inc   0.59 $ 26.453  Millions$ 44.474  Millions
Advanced Container Technologies Inc   0.57 $ 0.548  Millions$ 0.965  Millions
National Research Corporation  0.56 $ 31.591  Millions$ 56.729  Millions
Koninklijke Philips Nv  0.48 $ 6,389.600  Millions$ 13,329.120  Millions
Natera inc   0.47 $ 250.011  Millions$ 536.000  Millions
Miragen Therapeutics Inc   0.42 $ 8.834  Millions$ 21.042  Millions
Psychemedics Corp  0.33 $ 4.302  Millions$ 12.942  Millions
Enzo Biochem Inc  0.19 $ 11.447  Millions$ 59.018  Millions
Icon Plc  0.19 $ 348.477  Millions$ 1,850.236  Millions
American Shared Hospital Services  0.16 $ 4.937  Millions$ 30.714  Millions
Castle Biosciences Inc   0.13 $ 22.455  Millions$ 166.559  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com